Experts convene at 12th Annual Clinical Trials in Oncology meeting to discuss future strategies
From Yahoo Finance: 2025-04-24 10:19:00
Experts from pharmaceutical, biotech companies, CROs, and cancer centers will meet at the 12th Annual Clinical Trials in Oncology meeting to discuss trends and strategies for success in oncology trials. Keynote presentations will cover CAR-T therapies, regulatory impacts, and the future of oncology trials, with a focus on patient recruitment and engagement.
The conference will feature sessions on clinical trial operations, patient recruitment, and engagement strategies in oncology. Topics include operational efficiencies, risk-based quality management, and patient-centric trial designs. Industry leaders will discuss the future of oncology trials in 2025, global market influences, and advancements in AI.
Day two will include roundtable discussions on patient enrollment strategies and clinical operations integration. Key themes will focus on collaboration between CROs and biotechs, sustainability in clinical trials, and the use of iPSCs. GlobalData’s Director of Oncology will provide insights on oncology cell therapies and future forecasts.
The 12th Annual Clinical Trials in Oncology conference, organized by Arena International Events Group, will bring together experts to redefine the future of clinical trials in oncology. Attendees can engage with industry leaders, discuss patient enrollment strategies, and explore the landscape of oncology cell therapies.
Read more: Redefining the future of clinical trials in oncology